Evoke plc (LON:EVOK – Get Free Report)’s share price was down 10% during mid-day trading on Thursday . The company traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). Approximately 65,066,164 shares traded hands during trading, an increase of 1,994% from the average daily volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Analyst Upgrades and Downgrades
EVOK has been the subject of several analyst reports. Berenberg Bank reduced their target price on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating for the company in a report on Wednesday, December 4th. Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 140 ($1.81) price objective on shares of Evoke in a research note on Monday, December 16th.
Read Our Latest Stock Analysis on EVOK
Evoke Price Performance
Evoke (LON:EVOK – Get Free Report) last announced its quarterly earnings data on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share (EPS) for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. On average, equities analysts anticipate that Evoke plc will post 12.7648305 earnings per share for the current year.
Insider Buying and Selling
In related news, insider Andrea Gisle Joosen purchased 14,572 shares of the stock in a transaction dated Tuesday, January 28th. The shares were acquired at an average cost of GBX 70 ($0.91) per share, for a total transaction of £10,200.40 ($13,202.69). 27.00% of the stock is currently owned by corporate insiders.
About Evoke
Further Reading
- Five stocks we like better than Evoke
- What is the Australian Securities Exchange (ASX)
- MarketBeat Week in Review – 03/24 – 03/28
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Investing in Commodities: What Are They? How to Invest in Them
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.